| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.004 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.007 |